TD Asset Management Inc Has $2.32 Million Stock Holdings in Oscar Health, Inc. $OSCR

TD Asset Management Inc reduced its position in Oscar Health, Inc. (NYSE:OSCR) by 63.1% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 122,544 shares of the company’s stock after selling 209,946 shares during the period. TD Asset Management Inc’s holdings in Oscar Health were worth $2,320,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of OSCR. Envestnet Asset Management Inc. boosted its position in Oscar Health by 200.9% during the second quarter. Envestnet Asset Management Inc. now owns 30,210 shares of the company’s stock worth $648,000 after purchasing an additional 20,171 shares during the period. Udine Wealth Management Inc. lifted its position in Oscar Health by 138.4% during the third quarter. Udine Wealth Management Inc. now owns 146,555 shares of the company’s stock worth $2,774,000 after acquiring an additional 85,083 shares during the last quarter. Q Fund Management Hong Kong Ltd bought a new stake in shares of Oscar Health during the third quarter worth approximately $5,940,000. Jump Financial LLC increased its stake in shares of Oscar Health by 798.3% during the second quarter. Jump Financial LLC now owns 1,441,506 shares of the company’s stock worth $30,906,000 after purchasing an additional 1,281,032 shares during the period. Finally, State of Michigan Retirement System bought a new position in shares of Oscar Health during the third quarter worth approximately $27,448,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Up 10.6%

OSCR stock opened at $15.12 on Thursday. The firm has a 50-day moving average price of $14.68 and a 200-day moving average price of $16.61. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.80. The company has a current ratio of 0.96, a quick ratio of 0.96 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $4.50 billion, a P/E ratio of -8.69 and a beta of 1.91.

Oscar Health (NYSE:OSCR) last posted its earnings results on Tuesday, February 10th. The company reported ($1.24) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.32). Oscar Health had a negative return on equity of 39.35% and a negative net margin of 3.79%.The company had revenue of $2.81 billion for the quarter, compared to the consensus estimate of $3.12 billion. During the same period in the previous year, the firm posted ($0.62) EPS. The business’s quarterly revenue was up 17.3% compared to the same quarter last year. As a group, equities research analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Insider Buying and Selling at Oscar Health

In other news, insider Mario Schlosser sold 23,038 shares of the business’s stock in a transaction that occurred on Thursday, January 8th. The shares were sold at an average price of $17.65, for a total value of $406,620.70. Following the transaction, the insider owned 350,180 shares in the company, valued at approximately $6,180,677. The trade was a 6.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders sold a total of 138,835 shares of company stock valued at $2,298,269 over the last ninety days. Corporate insiders own 24.39% of the company’s stock.

Analyst Ratings Changes

OSCR has been the topic of several recent research reports. Piper Sandler upgraded Oscar Health from a “neutral” rating to an “overweight” rating and increased their price objective for the stock from $13.00 to $25.00 in a research report on Tuesday, November 25th. UBS Group reissued a “neutral” rating and issued a $15.00 price objective on shares of Oscar Health in a report on Wednesday, February 11th. Raymond James Financial raised shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price on the stock in a report on Thursday, February 12th. Wells Fargo & Company reduced their price target on Oscar Health from $14.00 to $11.00 and set an “underweight” rating on the stock in a research report on Thursday, November 13th. Finally, Wall Street Zen upgraded Oscar Health from a “sell” rating to a “hold” rating in a research note on Saturday, February 14th. Two analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $16.88.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.